Benjamin Looker
General Counsel chez ESPERION THERAPEUTICS, INC.
Fortune : 492 217 $ au 31/03/2024
Profil
Benjamin O.
Looker is currently working as the Secretary & General Counsel at Esperion Therapeutics, Inc. Prior to this, he held the position of Associate General Counsel-Oncology at Merck KGaA.
In 2021, he briefly served as the General Counsel at Trillium Therapeutics ULC.
He also worked as an Associate at Goodwin Procter LLP.
From 2019 to 2021, he was the VP, Head-US Legal & Global Business Operations at MorphoSys US, Inc. Mr. Looker completed his undergraduate studies at Boston College and obtained his graduate degree from Boston College Law School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/03/2024 | 183 663 ( 0,11% ) | 492 217 $ | 31/03/2024 |
Postes actifs de Benjamin Looker
| Sociétés | Poste | Début |
|---|---|---|
| ESPERION THERAPEUTICS, INC. | General Counsel | 01/01/2022 |
Anciens postes connus de Benjamin Looker
| Sociétés | Poste | Fin |
|---|---|---|
| TRILLIUM THERAPEUTICS | General Counsel | 01/11/2021 |
| MorphoSys US, Inc. | General Counsel | 01/04/2021 |
Goodwin Procter LLP
 Goodwin Procter LLP Investment ManagersFinance Goodwin Procter LLP is a law firm which provides advice to companies in public and private enterprises. It provides services to financial, life sciences, private equity, real estate, and technolgy industries. The company was founded in 1912 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
| MERCK KGAA | Corporate Officer/Principal | - |
Formation de Benjamin Looker
| Boston College | Undergraduate Degree |
| Boston College Law School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MERCK KGAA | Health Technology |
| ESPERION THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Trillium Therapeutics ULC
 Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
Goodwin Procter LLP
Goodwin Procter LLP Investment ManagersFinance Goodwin Procter LLP is a law firm which provides advice to companies in public and private enterprises. It provides services to financial, life sciences, private equity, real estate, and technolgy industries. The company was founded in 1912 and is headquartered in Boston, MA. | Finance |
| MorphoSys US, Inc. |
